ONO-2910

DRUG2 trials

Sponsors

Ono Pharmaceutical Co. Ltd

Conditions

CIPN - Chemotherapy-Induced Peripheral NeuropathyHealthy Volunteers

Phase 1

Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects

CompletedNCT04504760

Ono Pharmaceutical Co. LtdHealthy Volunteers

Start: 2020-07-10End: 2021-03-18Updated: 2024-05-03

Phase 2

Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel

CompletedNCT06538272

Ono Pharmaceutical Co. LtdCIPN - Chemotherapy-Induced Peripheral Neuropathy

Start: 2023-08-31End: 2024-09-19Updated: 2025-04-03